These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 34666752)
1. Dual inhibition of α Decaris ML; Schaub JR; Chen C; Cha J; Lee GG; Rexhepaj M; Ho SS; Rao V; Marlow MM; Kotak P; Budi EH; Hooi L; Wu J; Fridlib M; Martin SP; Huang S; Chen M; Muñoz M; Hom TF; Wolters PJ; Desai TJ; Rock F; Leftheris K; Morgans DJ; Lepist EI; Andre P; Lefebvre EA; Turner SM Respir Res; 2021 Oct; 22(1):265. PubMed ID: 34666752 [TBL] [Abstract][Full Text] [Related]
2. Potential of αvβ6 and αvβ1 integrin inhibition for treatment of idiopathic pulmonary fibrosis. Bellani S; Molyneaux PL; Maher TM; Spagnolo P Expert Opin Ther Targets; 2024 Jul; 28(7):575-585. PubMed ID: 38949181 [TBL] [Abstract][Full Text] [Related]
3. A dual αvβ1/αvβ6 integrin inhibitor Bexotegrast (PLN-74809) ameliorates organ injury and fibrogenesis in fibrotic kidney disease. Mu Y; Liu J; Wu Q; Wang B; Hu T; Li Y; Yan X; Ma L; Tan Z Eur J Pharmacol; 2024 Nov; 983():176983. PubMed ID: 39243926 [TBL] [Abstract][Full Text] [Related]
4. Defining the mechanism of galectin-3-mediated TGF-β1 activation and its role in lung fibrosis. Calver JF; Parmar NR; Harris G; Lithgo RM; Stylianou P; Zetterberg FR; Gooptu B; Mackinnon AC; Carr SB; Borthwick LA; Scott DJ; Stewart ID; Slack RJ; Jenkins RG; John AE J Biol Chem; 2024 Jun; 300(6):107300. PubMed ID: 38641066 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic disease. Wilkinson AL; John AE; Barrett JW; Gower E; Morrison VS; Man Y; Pun KT; Roper JA; Luckett JC; Borthwick LA; Barksby BS; Burgoyne RA; Barnes R; Fisher AJ; Procopiou PA; Hatley RJD; Barrett TN; Marshall RP; Macdonald SJF; Jenkins RG; Slack RJ Eur J Pharmacol; 2021 Dec; 913():174618. PubMed ID: 34762934 [TBL] [Abstract][Full Text] [Related]
6. The αvβ1 integrin plays a critical in vivo role in tissue fibrosis. Reed NI; Jo H; Chen C; Tsujino K; Arnold TD; DeGrado WF; Sheppard D Sci Transl Med; 2015 May; 7(288):288ra79. PubMed ID: 25995225 [TBL] [Abstract][Full Text] [Related]
7. USP7 Promotes TGF-β1 Signaling by De-Ubiquitinating Smad2/Smad3 in Pulmonary Fibrosis. Tang F; Gong H; Ke T; Yang W; Yang Y; Liu Z Discov Med; 2024 Aug; 36(187):1616-1626. PubMed ID: 39190377 [TBL] [Abstract][Full Text] [Related]
8. Amplification of TGFβ Induced ITGB6 Gene Transcription May Promote Pulmonary Fibrosis. Tatler AL; Goodwin AT; Gbolahan O; Saini G; Porte J; John AE; Clifford RL; Violette SM; Weinreb PH; Parfrey H; Wolters PJ; Gauldie J; Kolb M; Jenkins G PLoS One; 2016; 11(8):e0158047. PubMed ID: 27494713 [TBL] [Abstract][Full Text] [Related]
10. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway. Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477 [TBL] [Abstract][Full Text] [Related]
11. Mimosa pudica L. extract ameliorates pulmonary fibrosis via modulation of MAPK signaling pathways and FOXO3 stabilization. Nguyen QC; Nguyen HA; Pham TA; Tran VT; Nguyen TD; Pham DV J Ethnopharmacol; 2024 Aug; 330():118226. PubMed ID: 38670401 [TBL] [Abstract][Full Text] [Related]
12. Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis. John AE; Graves RH; Pun KT; Vitulli G; Forty EJ; Mercer PF; Morrell JL; Barrett JW; Rogers RF; Hafeji M; Bibby LI; Gower E; Morrison VS; Man Y; Roper JA; Luckett JC; Borthwick LA; Barksby BS; Burgoyne RA; Barnes R; Le J; Flint DJ; Pyne S; Habgood A; Organ LA; Joseph C; Edwards-Pritchard RC; Maher TM; Fisher AJ; Gudmann NS; Leeming DJ; Chambers RC; Lukey PT; Marshall RP; Macdonald SJF; Jenkins RG; Slack RJ Nat Commun; 2020 Sep; 11(1):4659. PubMed ID: 32938936 [TBL] [Abstract][Full Text] [Related]
13. Reversion of in vivo fibrogenesis by novel chromone scaffolds. Kim HS; Yoon YM; Meang MK; Park YE; Lee JY; Lee TH; Lee JE; Kim IH; Youn BS EBioMedicine; 2019 Jan; 39():484-496. PubMed ID: 30611717 [TBL] [Abstract][Full Text] [Related]
15. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis. Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491 [No Abstract] [Full Text] [Related]
16. The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow-Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats. Gad ES; Salama AAA; El-Shafie MF; Arafa HMM; Abdelsalam RM; Khattab M Inflammation; 2020 Feb; 43(1):123-134. PubMed ID: 31646446 [TBL] [Abstract][Full Text] [Related]
17. Vardenafil Activity in Lung Fibrosis and In Vitro Synergy with Nintedanib. Bourne MH; Kottom TJ; Hebrink DM; Choudhury M; Leof EB; Limper AH Cells; 2021 Dec; 10(12):. PubMed ID: 34944010 [TBL] [Abstract][Full Text] [Related]
18. Epithelial-mesenchymal interactions in fibrosis and repair. Transforming growth factor-β activation by epithelial cells and fibroblasts. Sheppard D Ann Am Thorac Soc; 2015 Mar; 12 Suppl 1(Suppl 1):S21-3. PubMed ID: 25830829 [TBL] [Abstract][Full Text] [Related]
19. The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis. Liang H; Xu C; Pan Z; Zhang Y; Xu Z; Chen Y; Li T; Li X; Liu Y; Huangfu L; Lu Y; Zhang Z; Yang B; Gitau S; Lu Y; Shan H; Du Z Mol Ther; 2014 Jun; 22(6):1122-1133. PubMed ID: 24594795 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis. Xie Y; Jiang H; Zhang Q; Mehrotra S; Abel PW; Toews ML; Wolff DW; Rennard S; Panettieri RA; Casale TB; Tu Y Respir Res; 2016 Aug; 17(1):103. PubMed ID: 27549302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]